J&J’s COVID-19 shot scores safety backing from CDC experts but booster need left for FDA nhigginsdunn Thu, 07/22/2021 – 16:32 More: J&J’s COVID-19 shot scores safety backing from CDC experts but booster need left for FDA Source: fierce
read moreOnce conditional, Merck’s Keytruda, Eisai’s Lenvima win full approval for endometrial cancer kdunleavy Thu, 07/22/2021 – 12:10 More: Once conditional, Merck's Keytruda, Eisai's Lenvima win full approval for endometrial cancer Source: fierce
read moreBiogen execs blame critics, the media for spurring ‘misinformation’ as Aduhelm launch lags expectations nhigginsdunn Thu, 07/22/2021 – 11:25 More: Biogen execs blame critics, the media for spurring 'misinformation' as Aduhelm launch lags expectations Source: fierce
read moreRoche pharma chief pegs $2B boost to Polivy’s potential lymphoma expansion as drugmaker weathers biosimilars aliu Thu, 07/22/2021 – 10:51 More: Roche pharma chief pegs B boost to Polivy's potential lymphoma expansion as drugmaker weathers biosimilars Source: fierce
read moreA $200M injection from the U.S. will allow Aspen to produce more Johnson & Johnson COVID-19 vaccines for Africa kdunleavy Thu, 07/22/2021 – 10:27 More: A 0M injection from the U.S. will allow Aspen to produce more Johnson & Johnson
read morePFIC is a rare and progressive liver disease affecting young children which can lead to cirrhosis and liver failure More: Albireo’s Bylvay approved in EU and US for rare paediatric liver disease Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals